Skip to content
Recall Observatory FDA recall evidence

Drug product

Methylphenidate Hydrochloride Extended-release Tablets, USP, 36 mg, 100-count bottle, Rx only, Trigen Laboratories, LLC Bridgewater, NJ 08807. NDC 13811-708-10

D-0581-2018

February 28, 2018

Class III

Product summary

Firm
Osmotica Pharmaceutical Corp
Event
Event 79365
Status
Terminated
Classification
Class III
Quantity
19,664 100-bottles
Official record key
drug-enforcement:D-0581-2018

Official wording

Reason: Subpotent Drug:100-count product bottle labeled as Methylphenidate HCL ER Tablets 36 mg found to contain 1 27 mg Methylphenidate HCL ER Tablet.

Code information: Lots: 170231B, 170232A, 170233A, 170234A

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent